Boosting anandamide in adolescent rats reversed schizophrenia-like cognitive and social deficits through CB1 and CB2 receptors
Blocking anandamide breakdown in adolescent rats prevented cognitive and social impairments caused by earlier NMDA receptor disruption, with social effects mediated by CB1 and cognitive effects by CB2 receptors.
Quick Facts
What This Study Found
The anandamide hydrolysis inhibitor URB597, given in late adolescence, reversed both novel object recognition deficits (via CB2 receptors) and social interaction abnormalities (via CB1 receptors) induced by early-adolescence MK-801 administration, while also normalizing glutamate and GABA marker expression in the prefrontal cortex.
Key Numbers
CB1 receptor mediated the reversal of social deficits; CB2 receptor mediated the reversal of cognitive deficits. URB597 also reversed glutamate and GABA abnormalities in the prelimbic prefrontal cortex.
How They Did This
Male rats received the NMDA receptor blocker MK-801 in early adolescence to induce schizophrenia-like symptoms, then received the anandamide hydrolysis inhibitor URB597 in late adolescence. Behavioral testing (novel object recognition, social interaction) and mRNA expression analysis of glutamate and GABA markers were performed in adulthood.
Why This Research Matters
This study identifies specific endocannabinoid receptor pathways for distinct schizophrenia symptoms, suggesting that targeting CB1 vs. CB2 receptors could address different symptom domains.
The Bigger Picture
The finding that different cannabinoid receptors mediate rescue of different symptom types (social vs. cognitive) suggests the endocannabinoid system could be a target for treatment-resistant symptoms of schizophrenia, which current antipsychotics often fail to address.
What This Study Doesn't Tell Us
Animal model only. MK-801 model does not fully replicate human schizophrenia. Only male rats tested. The therapeutic window (late adolescence) may not translate directly to human clinical application.
Questions This Raises
- ?Would similar effects be seen in female rats?
- ?Could selective CB2 agonists improve cognition in people with schizophrenia?
- ?Is there a critical window for endocannabinoid intervention?
Trust & Context
- Key Stat:
- CB1 reversed social deficits; CB2 reversed cognitive deficits
- Evidence Grade:
- Rigorous animal study with clear mechanistic findings, but translation to humans is uncertain.
- Study Age:
- Published in 2022.
- Original Title:
- Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects.
- Published In:
- Schizophrenia bulletin, 48(4), 795-803 (2022)
- Authors:
- Bauminger, Hagar, Zaidan, Hiba, Akirav, Irit(5), Gaisler-Salomon, Inna
- Database ID:
- RTHC-03697
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
How did the researchers create schizophrenia-like symptoms in rats?
They gave rats the NMDA receptor blocker MK-801 in early adolescence, which produced lasting cognitive deficits and social interaction problems similar to negative symptoms and cognitive deficits seen in schizophrenia.
What is URB597 and how does it work?
URB597 blocks the enzyme that breaks down anandamide, one of the brain's natural endocannabinoids. This increases anandamide levels, which then acts on CB1 and CB2 receptors to normalize behavior and brain chemistry.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-03697APA
Bauminger, Hagar; Zaidan, Hiba; Akirav, Irit; Gaisler-Salomon, Inna. (2022). Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects.. Schizophrenia bulletin, 48(4), 795-803. https://doi.org/10.1093/schbul/sbab153
MLA
Bauminger, Hagar, et al. "Anandamide Hydrolysis Inhibition Reverses the Long-Term Behavioral and Gene Expression Alterations Induced by MK-801 in Male Rats: Differential CB1 and CB2 Receptor-Mediated Effects.." Schizophrenia bulletin, 2022. https://doi.org/10.1093/schbul/sbab153
RethinkTHC
RethinkTHC Research Database. "Anandamide Hydrolysis Inhibition Reverses the Long-Term Beha..." RTHC-03697. Retrieved from https://rethinkthc.com/research/bauminger-2022-anandamide-hydrolysis-inhibition-reverses
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.